baber/WOPTO huggingface dataset:
Patent NZ-270086-A (NZ)
Title: Process for preparing 3-quinolonecarboxylic acid derivatives
Inventor: ZERBES RUDOLF
IPC: C07D471/04
Filed: 1994-12-07
Abstract: The present invention relates to a one-pot process for the preparation of 7-heterocyclyl-substituted 3-quinolonecarboxylic acid derivatives. They have a strong antimicrobial action and include active compounds such as ofloxacin, ciprofloxacin or enrofloxacin.
Patent NZ-275325-A (NZ)
Title: 3,4,6-trisubstitutedpyran-2-one derivatives
Inventor: DOMAGALA JOHN MICHAEL
IPC: C07D403/06
Filed: 1994-10-26
Abstract: The present invention relates to novel tri- and tetrasubstituted pyrones and related structures which potently inhibit the HIV aspartyl protease blocking HIV infectivity. The pyrone derivatives are useful in the development of therapies for the treatment of bacterial and viral infections and diseases, including AIDS. The present invention is also directed to methods of synthesis of multifunctionalized pyrones and of related structures.
Patent NZ-284174-A (NZ)
Title: Topical dressing for (trans)dermal administration of a substance
Inventor: NYQVIST-MAYER ADELA
IPC: A61M35/00
Filed: 1995-04-05
Abstract: PCT No. PCT/SE95/00368 Sec. 371 Date Aug. 22, 1996 Sec. 102(e) Date Aug. 22, 1996 PCT Filed Apr. 5, 1995 PCT Pub. No. WO95/26778 PCT Pub. Date Oct. 12, 1995A topical dressing for dermal or transdermal administration of a substance, comprising a backing structure comprising a disc, a pad containing the active substance, a resilient layer with an adhesive provided on one side thereof, the resilient layer and the adhesive being provided with a cut-out defining a cavity in which the pad is placed, the disc of the backing structure being provided on the side of the resilient layer remote from the side provided with the adhesive and partly covering the resilient layer, and a covering structure having a release layer and a dish, the dish being formed to receive the pad during production and storage of the dressing, said covering structure being provided on the adhesive side of the resilient layer, whereby the backing structure is provided with one or more strips extending outwardly from the periphery edge of the backing disc towards the periphery edges of the resilient layer and in that the cover structure and the backing structure are sealed together within the cavity. There is also provided a method of producing a topical dressing according to the invention.
Patent NZ-295211-A (NZ)
Title: Topical aqueous gel containing a water-soluble cellulose derivative, propylene glycol & drug(s) for haemorrhoids
Inventor: BLANCO AMPARO
IPC: A61K9/06
Filed: 1995-11-09
Abstract: his application concerns an aqueous gel composition for treating haemorrhoids and/or anorectal disorders in a human by administration intrarectally and/or to the anorectal region which contains one or more drugs effective in treating haemorrhoids and a carrier comprising a water soluble cellulose derivative as gelling agent in an amount from 0.2 % to 10 % by weight of the total composition, propylene glycol in an amount of from 5 % to 45 % by weight of the total composition and water in an amount up to 94 % by weight of the total composition.
Patent NZ-319425-A (NZ)
Title: Polynucleic acids that encode a mutant or chimeric lantibiotic, nisin or subtilin that have enhanced stability and activity
Inventor: HANSEN J NORMAN
IPC: C12P21/04
Filed: 1996-09-30
Abstract: Nisin-subtilin mutant and chimeric prepeptides were constructed and expressed in a Bacillus subtilis strain that possesses all of the cellular machinery for making subtilin, except for the presubtilin gene. The chimera SL-Nis1-11-Sub12-32 was prepared. The prepeptide has the subtilin leader sequence (SL), the N-terminal portion of the structural region was derived from nisin, and the C-terminal portion of the structural region derived from subtilin. This chimera was accurately and efficiently converted to the mature lantibiotic, as demonstrated by a variety of physical and biological activity assays. In contrast, a (SL-Sub1-11-Nis12-34) chimera was processed into a heterogeneous mixture of products, none of which appeared to be the correct chimeric lantibiotic. The mixture did, however, contain an active minor component with a biological activity that exceeded nisin itself.
Patent NZ-320205-A (NZ)
Title: Process for the preparation of an ice confection
Inventor: HALL GORDON
IPC: A23G9/06
Filed: 1996-10-10
Abstract: A process for the manufacture of a frozen spoonable water-ice comprising the steps of: (i) producing of ice flakes at a temperature of -10 DEG  C. or below, preferably -20 DEG  C. or below; (ii) grinding the ice flakes produced in step (i) into approximately spherical ice granules at a temperature of -10 DEG  C. or below, preferably -20 DEG  C. or below; (iii) mixing the ice granules produced in step (ii) with a flavoured ice slurry; and (iv) packaging the mixture obtained in step (iii) and freezing for storage.
Patent NZ-329623-A (NZ)
Title: Ostomy device comprising a pouch, tap mounting washer with two openings, a removable disk for the second opening and a tap
Inventor: CLINE JOHN B
IPC: A61F5/44
Filed: 1997-03-26
Abstract: Measurements of the topography of the stomal area of the patient are taken manually, by photographs taken at different angles, computerized touch probing, magnetic resonance imaging, computerized axial tomography, laser scanning or by casting. Information relating to the measurements is recorded on a card, a template or electronically. The recorded information is digitized and stored in a database, along with information concerning patent history and preferences. The electronic information is utilized to select the physical attributes of the wafer and pouch which best suit the needs of the user. The appropriate tools are automatically selected, adjusted and guided to fabricate customized wafers and pouches by computerized fabrication equipment. Parameters which can be varied include the size, shape and location of the stoma receiving opening, the wafer outline and surface contour, the adhesive type, the pouch size and shape, the tail location, the tap type and location, the flange style and the filter location, as well as the accessories which are required. <IMAGE>
Patent NZ-334132-A (NZ)
Title: Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide
Inventor: TALLEY JOHN J
IPC: C07D/
Filed: 1997-08-12
Abstract: A crystalline Form B of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide, having a melting point of about 170-174oC, may be used in the preparation of a medicament for the treatment or prevention of a cyclooxygenase-2-associated disorder, e.g. inflammation, arthritis or pain, in a subject.  A method of preparing Form B may comprise recrystallizing 4- [5-methyl-3-phenylisoxazol-4-yl]benezenesulfonamide using an alcohol based solvent system, the solvent selected from methanol, isopropanol, aqueous methanol and aqueous ethanol.
Patent NZ-336093-A (NZ)
Title: Phenyl substituted aminoguanidine and alkoxyguanidine derivatives useful as protease inhibitors
Inventor: TOMCZUK BRUCE E
IPC: C07C279/10
Filed: 1997-11-26
Abstract: The aminoguanidine and alkoxyguanidine derivative or a solvate, hydrate or pharmaceutically acceptable salt thereof has the formula I wherein:  R' is optionally substituted alkyl, cycloalkyl, alkenyl, alkynyl, aryl, aralkyl or heteroaryl; Z is -NR10SO2-, -SO2NR10-, -NR10C(RyRz)-, -C(RyRz)NR10-, -OSO2-, -SO2O-, -OC(RyRz)-, -C(RyRz)O-, -NR10CO- or -CONR10-; RY and RZ are independently hydrogen, alkyl, cycloalkyl, aryl, aralkyl, hydroxyalkyl, carboxyalkyl, aminoalkyl, monoalkylaminoalkyl, dialkylaminoalkyl or carboxy; R2, R3 and R4 are independently hydrogen, alkyl, cycloalkyl, alkenyl, alkynyl, aryl, aralkyl, heteroaryl, trifluoromethyl, halogen, hydroxyalkyl, cyano, nitro, carboxamido, -CO2RX, -CH2ORX or ORX, or when present on adjacent carbon atoms, R2 and R3 may also be taken together to form one of -CH =CH-CH=CH- or -(CH2)q'- while R4 is defined as above; q' is from 2 to 6 each RX is independently hydrogen or optionally unsaturated alkyl or cycloalkyl; Y is -O-, -NR10-, - S-, -CHR10- or a covalent bond; X is oxygen or NR9; R9 is hydrogen or optionally substituted alkyl, cycloalkyl or aryl; R6 is hydrogen, alkyl, aralkyl, aryl, hydroxyalkyl, aminoalkyl, monoalkylamino alkyl, dialkylamino alkyl or carboxyalkyl or R6 and R12 are taken together to form -(CH2)w; w is 1 to 5; R7 is hydrogen, alkyl, aralkyl, hydroxyalkyl, aminoalkyl, monoalkylaminoalkyl, dialkylaminoalkyl, carboxyalkyl, hydroxy, alkoxy, aralkoxy, heteroaryloxy, mono or di alkylamino provided than n is other than zero when R7 is hydroxy, alkoxy, aralkoxy, aryloxy, heteroaryloxy or mono or di alkylamino; R8, R11 and R12 are independently hydrogen, alkyl, aralkyl, aryl, hydroxyalkyl, aminoalkyl, monoalkylaminoalkyl, dialkylaminoalkyl or carboxyalkyl or R7 and R8 are taken together to form -(CH2)y- while R11 and R12 are defined as above or R7 and R12 are taken together to form -CH2)q while R8 and R11 are defined as above or R8 and R11 are taken together to form -(CH2)r- while R7 and R12 are defined as above; r is 2-8; y is 0 to 2; q is 0 to 8; each R10 is independently hydrogen, alkyl, aralkyl, aryl, hydroxyalkyl, aminoalkyl, monoakylamino alkyl, dialkylamino alkyl or carboxyalkyl; Ra, Rb and Rc are independently hydrogen, alkyl, hydroxy, alkoxy, aryloxy, aralkoxy, alkoxycarbonyloxy, cyano or -CO2Rw; Rw is alkyl, cycloalkyl, phenyl, benzyl or a group of formula II; Rd and Re are independently hydrogen, alkyl, alkenyl or phenyl; Rf is hydrogen, alkyl, alkenyl or phenyl, Rg is hydrogen, alkyl, alkenyl or phenyl; Rh is aralkyl or alkyl; n is 0 to 8 and m is 0 to 4.  A pharmaceutical composition thereof is useful for inhibiting proteolysis or for treating pancreatitis, thrombosis, ischemica, stroke, emphysema or inflammation.
Patent NZ-336961-A (NZ)
Title: Polymer blend comprising a polyester, a polyfunctional acid anhydride and a polyhydric alcohol
Inventor: VAN DIEPEN GARY
IPC: C08K5/05
Filed: 1998-01-30
Abstract: A polymer blend comprising a polyester, a polyfunctional acid anhydride wherein said polyfunctional acid anhydride has a functionality as described herein of three or more, and a polyhydric alcohol or precursor thereto wherein said polyhydric alcohol has a functionality of three or more, and wherein said molar ratio of said polyfunctional acid anhydride to the polyhydric alcohol or precursor thereto is in the range of 0.5:1 to (10xC):1, where C is the number of moles of alcohol or equivalent in the polyhydric alcohol or precursor thereto.
Patent NZ-501436-A (NZ)
Title: Game controller with joystick type controls for controlling character movement
Inventor: TAKATSUKA SUSUMU
IPC: A63F13/06
Filed: 1999-11-30
Abstract: A program causes the little guy 201 to wield his light saber 202 on the display screen of the entertainment system in accordance with the movement of the operator's fingers on the game controller device.  The finger movements are related to how the object carried by the game character appears to move.
Patent NZ-503399-A (NZ)
Title: Phthalazine derivatives, a process for their production; and remedies for erectile dysfunction and female sexual disfunction or dysmenorrhea
Inventor: WATANABE NOBUHISA
IPC: C07D498/08
Filed: 1999-02-17
Abstract: A phthalazine compound as a therapeutic agent for erectile dysfunction represented by formula (I), and its salt or a hydrate: wherein R1 and R2 are the same or different from each other and represent a halogen, a C1 to C4 alkyl group which may be substituted with a halogen, a C1 to C4 alkoxy group which may be substituted with a halogen or a cyano group; X is cyano, a nitro, a halogen, a thiocarbamoyl group, a hydroxyimino group which may be substituted with a C1 to C4 alkyl group, an aryl C1 to C4 alkyl group or a carboxy C1 to C4 alkyl group, or a heteroaryl group selected from pyrrole, pyrazole, imidazole triazole, tetrazole, thiazole, isothiazole, thiadiazole, pyridine, pyrimidine and triazine, optionally having 1 to 3 substituent groups as described in the specification; and Y is as described in the specification.
Patent NZ-503991-A (NZ)
Title: Use of quinazoline derivatives as tyrosine kinase inhibitors for treating colonic polyps
Inventor: FROST PHILIP
IPC: A61P43/00
Filed: 1998-11-04
Abstract: The use, in the manufacture of a medicament for the treatment of colonic polyps, of a compound of formula 1 wherein: X is phenyl optionally substituted with one or more substituents selected from the group consisting of halogen, alkyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, hydroxy, trifluoromethyl, cyano, nitro, carboxy, carboalkoxy of 2-7 carbon atoms, carboalkyl of 2-7 carbon atoms, amino, and alkanoylamino of 1- 6 carbon atoms; R and R1 are each, independently, hydrogen, halogen, alkyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, hydroxy, or trifluoromethyl; R2 is hydrogen, alkyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, hydroxy, trifluoromethyl; Y is a radical selected from the group consisting of formulae 2-8 wherein: R3 is independently hydrogen, alkyl of 1-6 carbon atoms, carboxy, carboalkoxy of 1-6 carbon atoms, phenyl, or carboalkyl of 2-7 carbon atoms; n = 2-4; with the proviso that each R3 of Y may be the same or different or a pharmaceutically acceptable salt thereof.
Patent NZ-509485-A (NZ)
Title: Powder coating compositions
Inventor: RING JOHN
IPC: C09D167/00
Filed: 1999-07-02
Abstract: A powder coating composition comprising a film-forming polymeric component having a d(v,50) in the range or from 25 to 50 microns or a d(v,70) in the range of from 25 to 70 microns, which composition incorporates by dry-blending at least one appearance-modifying additive component and a further component comprising wax-coated silica or consisting of alumina together with aluminium hydroxide. The appearance-modifying additive may be a gloss-reducing component, a texturing component, a metallic or mica component, a colouring pigment, or a further film-forming polymeric material comparable with the first film-forming polymeric material but differing in coloration from the first, and the further additive may be alumina together with aluminium hydroxide, wax-coated silica, or a combination thereof. Preferably, no more than 70% by volume of the particles in the film-forming polymeric material are less than 50 microns. A kit of the invention comprises the individual additive components prior to mixing. The kit allows for the flexible production of a variety of finishes from a gloss powder coating composition, for example, a matte, textured, metallic, or sparkle finish, a matte metallic finish, an antique finish, or a contrast texture or metallic sparkle finish.
Patent NZ-519201-A (NZ)
Title: Withdrawal and injection system for medical solutions and a container with said withdrawal and injection system
Inventor: HERBERT REINHOLD
IPC: A61J1/05
Filed: 2000-12-07
Abstract: A container, in particular, a film bag, with a withdrawal and injection system for medical solutions, which comprises a base section (2), which may be welded into the bag, with a withdrawal and an injection piece (3, 4), which are linked together by a flat bridge (35). The flat bridge (35) is extended in the form of a bulge, between the withdrawal piece (3) and the injection piece (4), which forms a closeable opening (34). Said opening (34) in the container serves as a way of filling the container, by means of a filling dowel, or for transport and positioning, by mean of a fixing dowel. Furthermore a container, in particular a bag, with such a withdrawal and injection system is described.
Patent NZ-519236-A (NZ)
Title: Use of fatty acid salts of alkoxylated oligoamines as lubricity improvers for petroleum products
Inventor: OPPENLANDER KNUT
IPC: C10L10/04
Filed: 2000-11-10
Abstract: The use of fatty acid salts of alkoxylated oligoamines of formula (I), wherein A is an alkylene group of 2 to 8 carbon atoms; R is C7- to C23-alkyl or mono- or polyunsaturated C7- to C23-alkenyl, which may additionally carry hydroxyl groups; Z is a C1- to C8-alkylene group, C3- to C8-cycloalkylene group or C6- to C12-arylene or arylalkylene group; m is an integer from 1 to 5 and the sum of all integers x has a value of from 50 to 300% of (m+3), as lubricity enhancers for mineral oil products.
Patent NZ-525973-A (NZ)
Title: Real estate transaction method and system
Inventor: GOTFRIED BRADLEY L
IPC: G06Q20/10
Filed: 2001-11-21
Abstract: A method is disclosed for brokering real estate transactions is disclosed whereby a broker allows a user to sell at least one first property and purchase at least one second property via a computer communications network. The method includes the steps of: (a) the broker purchasing a first property from the user; (b) the broker offering at least one second property to the user for purchase; (c) the broker receives from the user a selection of at least one second property selected from those offered by the broker to the user for purchase; (d) the broker transferring the sale proceeds from the sale transaction of the first property to the user, for use in purchasing the second property selected in step (c); and (e) executing a purchase transaction of the second property selected in step (c). The sale proceeds of the sale transaction of the first property is used as payment towards the purchase of the second property.
Patent NZ-526873-A (NZ)
Title: Formaldehyde-free coatings and acoustical panel
IPC: C09D7/12
Filed: 2003-07-04
Abstract: Disclosed are polymeric or polymerizable non-formaldehyde containing materials including a crosslinked grid and hydrophilic group chemically attached to the crosslinked grid. The composition further includes a compound such as mica, which has a modulus of elasticity of between 40 GPa to 250 GPa, The composition when applied on a panel as a back coating provides a substantial degree of sag resistance under humid conditions.
Patent NZ-528586-A (NZ)
Title: Process for making a flowable and meterable densified fiber particle from singulated cellulose fibers
Inventor: DEZUTTER RAMON CHARLES
IPC: D21B1/00
Filed: 2003-10-01
Abstract: A process for producing a readily dispersible, flowable, and meterable cellulosic product is disclosed, wherein the process comprises: singulating cellulose fibers to form a mass of singulated fibers, and densifying the singulated fibers and forming the fibers into discrete particles, wherein each of the particles comprise a plurality of cellulose fibers mechanically bonded together. These discrete particles have a density of at least 0.3 g/cc.
Patent NZ-537294-A (NZ)
Title: Ketoprofen-supplemented animal feed and use thereof in the simultaneous treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain
Inventor: HOMEDES BEGUER JOSEP
IPC: A23K1/16
Filed: 2003-05-29
Abstract: Disclosed is the use of a ketoprofen-supplemented animal feed for the simultaneous oral treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain in a herd of animals. Such diseases that may cause the fever, inflammation and/or pain include respiratory diseases such as Porcine Respiratory Disease Complex ( PRDC ) and Bovine Respiratory Disease ( BRS ). The composition may additionally comprise diluents, such as lactose, saccharose manitol, cellulose, xylitol, glycine or sorbitol, and fluidifiers, such as colloidal silicon dioxide, stearic acid, magnesium stearate or sodium stearylfumarate.
Patent NZ-540036-A (NZ)
Title: Rotary valve and valve seal assembly for rotary valve engine having hemispherical combustion chambers
Inventor: COATES GEORGE J
IPC: F01L7/16
Filed: 2003-12-16
Abstract: A valve arrangement for a rotary valve assembly for use in an internal combustion engine of the piston and cylinder type, wherein the cylinder combustion chamber is of the hemispherical type, the rotary valve assembly positioned within a two piece cylinder head, the cylinder head defining a plurality of drum accommodating cavities for receipt of a plurality of rotary intake valves 10 and rotary exhaust valves 11, the rotary intake valves 10 and the rotary exhaust valves 11 having a spherical section defined by two parallel planes of the sphere, the planes being disposed symmetrically about the center of the sphere, defining a spherical periphery and planar end walls, the rotary intake valves 10 and the rotary exhaust valves mounted on a shaft means within the drum accommodating cavities in gas tight sealing contact with an intake port and an exhaust port respectively, the rotary intake valve 10 and the rotary exhaust valve 11 having passageways there through for the introduction and interruption of fuel air mixture to the cylinder and the evacuation of exhaust gases from the cylinder respectively, the gas tight sealing contact of the rotary intake valve 10 and the rotary exhaust valve 11 of the intake port and the exhaust port, respectively, accomplished by a valve seal and a valve seat, the valve arrangement for the hemispherical combustion chamber including the intake port and the exhaust port in angled relationship with respect to each other, the intake port and the exhaust port defining a valve seat, the valve seat of the intake port and the valve seat of the outlet port in angled relationship with respect to each other, an intake valve seal and an exhaust valve seal positioned in the respective intake ports and the exhaust ports, the intake valve seal and the exhaust valve seal in non-planar angled relationship with respect to each other and in communication with the drum accommodating cavities for contact with the spherical rotary intake valve and the spherical rotary exhaust valve 11 respectively, wherein the intake valve seal and the exhaust valve seal are in 30 degree angular relationship with a plane defined by joinder of the two piece cylinder head.
Patent NZ-541637-A (NZ)
Title: Modulation of insulin like growth factor I receptor
Inventor: WRAIGHT CHRISTOPHER JOHN
IPC: A61P17/00
Filed: 2004-02-11
Abstract: Disclosed are compositions and methods for modulating the expression of growth factor gene. In particular disclosed are compounds, particularly oligonucleotide compounds, which, in preferred embodiments, hybridize with nucleic acid molecules encoding the Insulin Like Growth Factor I receptor (IGF-I receptor or IGF-IR) and in particular human IGF-IR. Such compounds are exemplified herein to modulate proliferation which is relevant to the treatment of proliferative and inflammatory skin disorders and cancer. It will be understood, however, that the compounds can be used for any other condition in which the IGF-IR is involved including inflammatory conditions.
Patent NZ-550244-A (NZ)
Title: Beam flange clamp
Inventor: CURTIN JAMES LAURENCE
IPC: A62B1/04
Filed: 2005-06-17
Abstract: A clamp for a universal beam 18, the clamp including a hook means 1 and at least one locking plate 8 with a stepped inner edge which is disposed on a support bar 2 and adapted for relative slidable adjustment over a range of beam 18 configurations whereby in use the clamp can be attached to the beam 18 by the slidable adjustment to engage respective beam flanges 19, 20 with the hook means 1 and the stepped inner edge of the at least one locking plate 8 in a manner to obtain a rigid load bearing beam mounting for the support bar 2.
Patent NZ-552515-A (NZ)
Title: Novel 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17beta-hydroxysteroid dehydrogenase type 1
Inventor: GEGE CHRISTIAN
IPC: A61K31/56
Filed: 2005-07-04
Abstract: The disclosure relates to 2-substituted D-homo-estra-1,3,5(10)-trienes of general formula (I) and their pharmaceutically acceptable salts, wherein R2 represents a C1-C8 alkyl, a C1-C8 alkyloxy group or a halogen atom, R13 represents a hydrogen atom or a methyl group, R17 represents a hydrogen atom or a fluorine atom, and the dotted lines in the B- and D- ring of the steroid molecule can be additional double bonds. The disclosure also relates to the pharmaceutically acceptable salts of said compounds, to the production thereof, and to the use of the same as medicaments for the prophylaxis and treatment of oestrogen-dependent diseases that can be influenced by the inhibition of 17beta-hydroxysteroid dehydrogenase type 1.